MoneyWorks4Me

Unjha Formulations - Quaterly Results

10 Nov 2022 Evaluate
The total revenue hovered 115.55% to Rs. 46.17 millions for the September 2022 quarter as against Rs. 21.42 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2022 of Rs. 5.50 millions grew from Rs.-2.02 millions Operating profit Margin for the quarter ended September 2022 improved to 5.76% as compared to -1.76% of corresponding quarter ended September 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 46.17 21.42 115.55 71.04 60.35 17.71 143.51 101.72 41.08
Other Income 0.09 0.00 0.00 0.10 0.32 -68.75 0.00 0.00 0.00
PBIDT 5.76 -1.76 -427.27 6.41 3.43 86.88 5.09 3.58 42.18
Interest 0.07 0.06 16.67 0.08 0.10 -20.00 1.32 1.73 -23.70
PBDT 5.69 -1.82 -412.64 6.33 3.33 90.09 3.77 1.85 103.78
Depreciation 0.19 0.20 -5.00 0.39 0.40 -2.50 0.76 0.81 -6.17
PBT 5.50 -2.02 -372.28 5.94 2.93 102.73 3.01 1.04 189.42
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.47 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 5.50 -2.02 -372.28 5.94 2.93 102.73 2.54 1.04 144.23
Equity 44.81 44.81 0.00 44.81 44.81 0.00 44.81 44.81 0.00
PBIDTM(%) 12.48 -8.22 -251.83 9.02 5.68 58.76 3.55 3.52 0.78
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..